We caught up with Prof Thomas Lüscher (Royal Brompton and Harefield Hospital and Imperial College, London, UK) on the association between gut microbiota, the gut microbiome and cardiovascular disease.
- What is known about the association between gut microbiome changes and cardiovascular disease? (0.38)
- Which gut microbiota–dependent metabolites are involved in the pathogenesis of cardiovascular disease? (2.49)
- What novel therapeutic strategies are being investigated for targeting the gut microbiome to improve cardiovascular outcomes? (5.44)
- Could you give us an overview about the most important recent studies? (9.44)
- What are the major gaps in our knowledge and what future studies are planned? (12.13)
Speaker disclosures: Professor Thomas Lüscher has nothing to declare in relation to this video interview.
Support: Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Professor Thomas Lüscher, September 2020.
Share this Video
Related Videos In Cardiovascular Disease
William Schulyer-Jones, ACC 2021 – Findings from the ADAPTIVE study
We were delighted to speak with Dr William Schulyer-Jones (Associate Professor of Medicine, Duke University School of Medicine, Durham, NC, USA) about the findings of the ADAPTABLE STUDY, a large randomized study assessing the benefits and long-term effectiveness of aspirin dosage (81 mg vs. 325mg) for patients with cardiovascular disease. Abstract title: Aspirin Dosing: A […]
Gustavo Samaja, ESC 2020 – Myocardial Infarction with no Obstructive Coronary Arteries
We spoke to Dr Gustavo Samaja (Policlinico Bancario, Buenos Aires, Argentina) about myocardial infarction with no obstructive coronary arteries (MINOCA), and especially its prevalence and importance during the COVID-19 pandemic. Questions Could you give us a brief overview of myocardial infarction with no obstructive coronary arteries (MINOCA)? (0:33) How prevalent is MINOCA and what […]
David Playford, ESC 2020 – Diastolic Function and Mortality Part 1
We spoke to Professor David Playford (University of Notre Dame, Perth, Australia) regarding diastolic function and dysfunction, the National Echo Database Australia (NEDA), and then focused on his recent study on diastolic function and mortality. Questions What are the prognostic implications of diastolic dysfunction? (0:07) How do you classify patients by diastolic function? (1:18) […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!